Nasal nitric oxide test to improve primary ciliary dyskinesia care
Part of Ear, nose & throat, Genetic & congenital, Lungs & breathing clinical trials.
This study tests whether a breathing test called nasal nitric oxide can help improve care for people with primary ciliary dyskinesia (PCD) or related lung/sinus problems. The goal is to see if the test can better guide diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of primary ciliary dyskinesia (PCD) or abnormal PCD test results
- You may also qualify if you have unexplained bronchiectasis or strong symptoms that suggest PCD
- You must be at least 2 years old
- A parent/guardian (or you, if able) must agree to join the study
- You must be able to understand the study and complete the nasal nitric oxide test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether special nose tests help doctors choose the best treatments for children with long-term breathing and airway symptoms. It may help your child get more targeted care based on the test results.
This study checks whether using “PCD diagnostics” helps clinicians make better care decisions for people being evaluated for PCD. You might be able to join if you’re referred for PCD diagnosis and can complete the study steps.
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
This registry study collects medical information and samples from children who may have or have been diagnosed with primary ciliary dyskinesia (PCD). It helps researchers better describe the condition and its causes in Chinese children.
This study looks at how chest physiotherapy affects lung function in people with primary ciliary dyskinesia (a lifelong condition affecting mucus movement in the lungs). It may help care teams understand which breathing therapies work best and how your lungs respond.
This study follows people with primary ciliary dyskinesia (PCD) and looks at their regular ear, nose, and throat (ENT) checkups over time. Your participation may help doctors better understand how ENT care should be followed in PCD.
Hear when a new Primary Ciliary Dyskinesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.